Connors JM - Search Results

1

Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months).

Venner CP, Connors JM, Sutherland HJ, Shepherd JD, Hamata L, Mourad YA, Barnett MJ, Broady R, Forrest DL, Hogge DE, Nantel SH, Narayanan S, Nevill TJ, Nitta J, Power MM, Toze CL, Smith CA, Song KW. Venner CP, et al. Among authors: connors jm. Leuk Lymphoma. 2011 Jan;52(1):34-41. doi: 10.3109/10428194.2010.531409. Epub 2010 Dec 6. Leuk Lymphoma. 2011. PMID: 21133716

2

Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988.

Lohri A, Barnett M, Fairey RN, O'Reilly SE, Phillips GL, Reece D, Voss N, Connors JM. Lohri A, et al. Among authors: connors jm. Blood. 1991 May 15;77(10):2292-8. Blood. 1991. PMID: 1709382 Free article.

3

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.

Reece DE, Barnett MJ, Connors JM, Fairey RN, Fay JW, Greer JP, Herzig GP, Herzig RH, Klingemann HG, LeMaistre CF, et al. Reece DE, et al. Among authors: connors jm. J Clin Oncol. 1991 Oct;9(10):1871-9. doi: 10.1200/JCO.1991.9.10.1871. J Clin Oncol. 1991. PMID: 1919637

4

Intensive chemotherapy and autologous peripheral blood stem cell transplantation in a patient with persistent marrow involvement with Hodgkin's disease.

Phillips GL, Reece DE, Lerner KG, Connors JM. Phillips GL, et al. Among authors: connors jm. Bone Marrow Transplant. 1990 Jul;6(1):45-7. Bone Marrow Transplant. 1990. PMID: 1975204

5

Allogeneic marrow transplantation for refractory Hodgkin's disease.

Phillips GL, Reece DE, Barnett MJ, Connors JM, Fay JW, Herzig GP, Herzig RH, Klingemann HG, Shepherd JD, Wolff SN. Phillips GL, et al. Among authors: connors jm. J Clin Oncol. 1989 Aug;7(8):1039-45. doi: 10.1200/JCO.1989.7.8.1039. J Clin Oncol. 1989. PMID: 2474058

6

Testicular lymphoma: improved outcome with early brief chemotherapy.

Connors JM, Klimo P, Voss N, Fairey RN, Jackson S. Connors JM, et al. J Clin Oncol. 1988 May;6(5):776-81. doi: 10.1200/JCO.1988.6.5.776. J Clin Oncol. 1988. PMID: 3367185

7

Is there a role for MACOP-B in the treatment of diffuse large cell lymphoma?

O'Reilly SE, Connors JM. O'Reilly SE, et al. Among authors: connors jm. Leuk Lymphoma. 1993;10 Suppl:85-9. doi: 10.3109/10428199309149118. Leuk Lymphoma. 1993. PMID: 7683229

8

Identification of risk factors in patients treated for first relapse of Hodgkin's disease.

Lohri A, Connors JM. Lohri A, et al. Among authors: connors jm. Leuk Lymphoma. 1994 Oct;15(3-4):189-200. doi: 10.3109/10428199409049715. Leuk Lymphoma. 1994. PMID: 7866268 Review.

9

Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy.

Reece DE, Connors JM, Spinelli JJ, Barnett MJ, Fairey RN, Klingemann HG, Nantel SH, O'Reilly S, Shepherd JD, Sutherland HJ, et al. Reece DE, et al. Among authors: connors jm. Blood. 1994 Mar 1;83(5):1193-9. Blood. 1994. PMID: 8118023 Free article. Clinical Trial.

10

Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma.

Shepherd JD, Barnett MJ, Connors JM, Spinelli JJ, Sutherland HJ, Kingemann HG, Nantel SH, Reece DE, Currie CJ, Phillips GL. Shepherd JD, et al. Among authors: connors jm. Bone Marrow Transplant. 1993 Dec;12(6):591-6. Bone Marrow Transplant. 1993. PMID: 8136743 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

761 results

Search Page

Filters